Sandra Abou Kassm1,2, Wadih Naja3,4, Ramzi Haddad3,4, Antoine Pelissolo5. 1. Faculty of Medical Sciences, Psychiatry Department, Lebanese University, Beirut, Lebanon. Sandra_akassm@hotmail.com. 2. Psychiatry Department, Mount Lebanon Hospital, P.O. Box 470, Blvd. Camille Chamoun, Hazmieh, Beirut, Lebanon. Sandra_akassm@hotmail.com. 3. Faculty of Medical Sciences, Psychiatry Department, Lebanese University, Beirut, Lebanon. 4. Psychiatry Department, Mount Lebanon Hospital, P.O. Box 470, Blvd. Camille Chamoun, Hazmieh, Beirut, Lebanon. 5. AP-HP Hôpital Henri Mondor, DMU IMPACT, Univ Paris-Est Créteil, INSERM U955, F-94010, Creteil, France.
Abstract
PURPOSE OF REVIEW: This paper seeks to describe anxiety's different symptomatologic presentations in Parkinson's disease (PD), its longitudinal course and predictors, as well as its motor and non-motor correlates. It also reviews the available screening tools and different treatment modalities. RECENT FINDINGS: In PD, longitudinal predictors of anxiety are mostly non-motor non-dopaminergic symptoms. The longitudinal course of anxiety is mainly a stable one. The Parkinson Anxiety Scale and the Geriatric Anxiety Scale are the 2 recommended screening tools. A third of PD patients suffer from an anxiety disorder at any time point. It can precede or follow PD motor symptoms. Anxiety is associated with demographic, disease-related motor and non-motor features. There is a lack of studies evaluating psychotropic treatment of anxiety in PD. Adjustment of dopaminergic treatment is indicated when anxiety is associated with motor fluctuations. DBS can be useful as well as CBT and body-mind interventions.
PURPOSE OF REVIEW: This paper seeks to describe anxiety's different symptomatologic presentations in Parkinson's disease (PD), its longitudinal course and predictors, as well as its motor and non-motor correlates. It also reviews the available screening tools and different treatment modalities. RECENT FINDINGS: In PD, longitudinal predictors of anxiety are mostly non-motor non-dopaminergic symptoms. The longitudinal course of anxiety is mainly a stable one. The Parkinson Anxiety Scale and the Geriatric Anxiety Scale are the 2 recommended screening tools. A third of PDpatients suffer from an anxiety disorder at any time point. It can precede or follow PD motor symptoms. Anxiety is associated with demographic, disease-related motor and non-motor features. There is a lack of studies evaluating psychotropic treatment of anxiety in PD. Adjustment of dopaminergic treatment is indicated when anxiety is associated with motor fluctuations. DBS can be useful as well as CBT and body-mind interventions.
Entities:
Keywords:
Anxiety; Motor fluctuations; Non-motor symptoms; Parkinson’s disease
Authors: Nancy A Pachana; Gerard J Byrne; Helen Siddle; Natasha Koloski; Emma Harley; Elizabeth Arnold Journal: Int Psychogeriatr Date: 2007-02 Impact factor: 3.878
Authors: Greg D Kuhlman; Joseph L Flanigan; Scott A Sperling; Matthew J Barrett Journal: Parkinsonism Relat Disord Date: 2019-05-07 Impact factor: 4.891
Authors: Sonja Rutten; Ires Ghielen; Chris Vriend; Adriaan W Hoogendoorn; Henk W Berendse; Albert F G Leentjens; Ysbrand D van der Werf; Jan H Smit; Odile A van den Heuvel Journal: Parkinsonism Relat Disord Date: 2014-12-10 Impact factor: 4.891
Authors: Zhong Jie Kua; Nancy A Pachana; Gerard J Byrne; John D O'Sullivan; Rodney Marsh; Elizabeth Torbey; Peter A Silburn; George D Mellick; Nadeeka N W Dissanayaka Journal: J Geriatr Psychiatry Neurol Date: 2018-08-02 Impact factor: 2.680
Authors: Andrew R Johnson; Blake J Lawrence; Emily J Corti; Leon Booth; N Gasson; Meghan G Thomas; A M Loftus; Romola S Bucks Journal: J Parkinsons Dis Date: 2016-05-27 Impact factor: 5.568
Authors: Ji Won Han; Yebin D Ahn; Won-Seok Kim; Cheol Min Shin; Seong Jin Jeong; Yoo Sung Song; Yun Jung Bae; Jong-Min Kim Journal: J Korean Med Sci Date: 2018-11-01 Impact factor: 2.153